Former Orthofix VP convicted in kickbacks scheme | Legal News Legal News

A former vice president of sales for Orthofix (NSDQ:OFIX) faces up to 5 years in prison after pleading guilty to federal charges that he helped run a scheme to pay doctors to use the company’s Spinal-Stim and Cervical-Stim bone growth stimulators.

Thomas P. Guerrieri, 51, of Youngstown, Ohio, yesterday copped to violating the Anti-Kickback statute in a Boston court. Had his case gone to trial, the feds would have proven that he set up a phony consulting deal with "Dr. S," 1 of Orthofix’s highest-prescribing customers, according to court documents. Orthofix paid out 10s of thousands of dollars to the physician in return for little or no work, according to federal prosecutors. The scheme also involved faking time sheets to make the deal seem legit, according to the documents; Guerrieri and a subordinate even went so far as to obtain a letter from Orthofix’s general counsel "indicating that the surgeon was compliant under his consulting agreement, which was not true," according to a press release.

"Guerrieri did these things to induce the surgeon to continue to order bone growth stimulators from the company," according to the release.

Sign up to get our free newsletters delivered straight to your inbox

The former sales VP also pleaded guilty to charges that he facilitated a deal with a Rhode Island physicians assistant named Michael Cobb to pay him for each stimulator he ordered for the surgeon’s practice. After Orthofix banned payments to prescribing surgeons’ office in 2008, Guerrieri and his accomplices "devised a scheme where Cobb continued to be paid for each order, but the payments were made by a vendor of the device company, making it more difficult to trace the paper trail," according to the release. Cobb is also facing federal kickbacks charges.

In addition to up to 5 years behind bars, Guerrieri faces a possible fine of $250,000 and forfeiture, according to the feds. A sentencing hearing is slated for July 11.

Orthofix itself is working with prosecutors to settle a trio of federal beefs, including a probe into its bone growth stimulator business. In February the Lewisville, Texas-based orthopedic device maker said it was finalizing agreements to close criminal and civil matters related to that issue and possible violations of the Foreign Corrupt Practices Act and the False Claims Act.

 Whistleblower asks court to re-open off-label stent case

Former Guidant Corp. regional sales director Kevin Colquitt asked a Texas federal court to reconsider his "qui tam" lawsuit accusing Boston Scientific (NYSE:BSX), Johnson & Johnson (NYSE:JNJ) and its Cordis Corp. subsidiary and Abbott (NYSE:ABT) of encouraging physicians to use the biliary stents to treat blocked blood vessels. The stents are designed to treat bile duct cancers and are not approved or cleared for other uses by the Food & Drug Administration. Read more

 Irish plaintiffs join DePuy lawsuit spree

About 200 Irish plaintiffs are planning to sue
Johnson & Johnson‘s (NYSE:JNJ) DePuy Orthopaedics subsidiary over allegedly faulty metal-on-metal hip implantsRead more

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply